Skip to main content
SpringerLink
Log in

Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Antiphospholipid syndrome (APS) is associated with adverse pregnancy outcomes including preeclampsia, recurrent early pregnancy loss, fetal death, and intrauterine growth restriction. Approximately one third of women with APS will develop preeclampsia during pregnancy. The association between antiphospholipid antibodies (aPL) in the absence of the clinical syndrome and preeclampsia is less clear, and a causal relationship has not yet been proven. Testing for aPL should be considered in women with early-onset (< 34 weeks) severe preeclampsia, eclampsia, or HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, especially when additional clinical features of APS are present. Prospective testing for aPL in women at risk for preeclampsia is not recommended. Current evidence does not justify inclusion of preeclampsia as a major criterion for APS, but preeclampsia could reasonably be included as a secondary or minor criterion in diagnosis when a patient has other clinical features of APS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Miyakis S, Lockshin MD, Atsumi T, et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295–306.

    Article  PubMed  CAS  Google Scholar 

  2. Reber G, Tincani A, Sanmarco M, et al.: European Forum on Antiphopholipid Antibodies Standardization Group. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost 2005, 94:665–672.

    PubMed  CAS  Google Scholar 

  3. Lubbe WF, Palmer SJ, Butler WS, et al.: Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983, i:1361.

    Article  Google Scholar 

  4. Branch DW, Scott JR, Kochenour NK, et al.: Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985, 313:1322–1326.

    Article  PubMed  CAS  Google Scholar 

  5. Lockshin MD, Druzin ML, Goei S, et al.: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985, 313:152–156.

    Article  PubMed  CAS  Google Scholar 

  6. Branch DW, Silver RM, Blackwell JL, et al.: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992, 80:614–620.

    PubMed  CAS  Google Scholar 

  7. Caruso A, de Carolis S, Ferrazzani S, et al.: Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993, 82:970–977.

    PubMed  CAS  Google Scholar 

  8. Lima F, Khamashta MA, Buchanan NM, et al.: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14:131–136.

    PubMed  CAS  Google Scholar 

  9. Huong DL, Wechsler B, Bletry O, et al.: A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001, 28:2025–2030.

    PubMed  CAS  Google Scholar 

  10. Pauzner R, Dulitzki M, Langevitz P, et al.: Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001, 86:1379–1384.

    PubMed  CAS  Google Scholar 

  11. Lockshin MD, Druzin ML, Qamar T: Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989, 160:439–443.

    PubMed  CAS  Google Scholar 

  12. Polzin WJ, Kopelman JN, Robinson RD, et al.: The association of aPL with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991, 78:1108–1111.

    PubMed  CAS  Google Scholar 

  13. Sletnes KE, Wisloff F, Moe N, et al.: Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992, 71:112–117.

    PubMed  CAS  Google Scholar 

  14. Yasuda M, Takakuwa K, Tokunaga A, et al.: Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995, 86:555–559.

    PubMed  CAS  Google Scholar 

  15. Pattison NS, Chamley LW, McKay EJ, et al.: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. BJOG 1993, 100:909–913.

    Article  CAS  Google Scholar 

  16. Lynch A, Marlar R, Murphy J, et al.: Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study. Ann Intern Med 1994, 120:470–475.

    PubMed  CAS  Google Scholar 

  17. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584–1589.

    Article  PubMed  CAS  Google Scholar 

  18. Milliez J, Lelong F, Bayani N, et al.: The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 1991, 165:51–56.

    PubMed  CAS  Google Scholar 

  19. Yamamoto T, Yoshimura S, Geshi Y, et al.: Measurement of antiphospholipid antibody by WLISA using purified beta2-glycoprotein I in preeclampsia. Clin Exp Immunol 1993, 94:196–200.

    Article  PubMed  CAS  Google Scholar 

  20. Moodley J, Bhoola V, Duursma J, et al.: The association of antiphospholipid antibodies with severe early-onset preeclampsia. S Afr Med J 1995, 85:105–107.

    PubMed  CAS  Google Scholar 

  21. Allen JY, Tapia-Santiago C, Kutteh WH: Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 1996, 36:81–85.

    PubMed  CAS  Google Scholar 

  22. Branch DW, Andres R, Digre KB, et al.: The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989, 73:541–545.

    PubMed  CAS  Google Scholar 

  23. Dekker GA, de Vries JI, Doelitzsch PM, et al.: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042–1048.

    Article  PubMed  CAS  Google Scholar 

  24. van Pampus MG, Dekker GA, Wolf H, et al.: High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999, 180:1146–1150.

    Article  PubMed  Google Scholar 

  25. Scott RA: Anticardiolipin antibodies and pre-eclampsia. BJOG 1987, 94:604–605.

    Article  CAS  Google Scholar 

  26. Out HJ, Bruinse HW, Christiaens GC, et al.: A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992, 167:26–32.

    PubMed  CAS  Google Scholar 

  27. Uncu G, Ozan H, Kucukerdogan I, et al.: Anticardiolipin antibodies in pregnancy induced hypertension. Eur J Obstet Gynecol Reprod Biol 1996, 70:97–100.

    Article  PubMed  CAS  Google Scholar 

  28. D’Anna R, Scilipoti A, Leonardi J, et al.: Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation. Clin Exp Obstet Gynecol 1997, 24:135–137.

    PubMed  CAS  Google Scholar 

  29. Martinez-Abundis E, Gonzalez-Ortiz M, Cortes-Llamas V, et al.: Anticardiolipin antibodies and the severity of preeclampsia-eclampsia. Gynecol Obstet Invest 1999, 48:168–171.

    Article  PubMed  CAS  Google Scholar 

  30. Matthiesen LS, Berg G, Ernerudh J, et al.: A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 1999, 83:21–26.

    Article  PubMed  CAS  Google Scholar 

  31. Dreyfus M, Hedelin G, Kutnahorsky R, et al.: Antiphospholipid antibodies and preeclampsia: A case-control study. Obstet Gynecol 2001, 97:29–34.

    Article  PubMed  CAS  Google Scholar 

  32. Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565–571.

    Article  PubMed  Google Scholar 

  33. Branch DW, Porter TF, Rittenhouse L, et al.: Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001, 184:825–832.

    Article  PubMed  CAS  Google Scholar 

  34. Zeeman GG, Alexander JM, McIntire DD, et al.: The significance of antiphospholipid antibodies in pregnant women with chronic hypertension. Am J Perinat 2004, 21:275–279.

    Article  Google Scholar 

  35. Katano K, Aoki A, Sasa H, et al.: Beta2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996, 11:509–512.

    PubMed  CAS  Google Scholar 

  36. Faden D, Tincani A, Tanzi P, et al.: Anti-beta 2 glycoprotein I antibodies in a general obstetric population: Preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2-glycoprotien I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997, 73:37–42.

    Article  PubMed  CAS  Google Scholar 

  37. Harris EN, Spinnato JA: Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991, 165:1272–1277.

    PubMed  CAS  Google Scholar 

  38. Lee RM, Brown MA, Branch DW, et al.: Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003, 102:294–300.

    Article  PubMed  CAS  Google Scholar 

  39. Branch DW, Khamashta MA: Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Am J Obstet Gynecol 2003, 101:1333–1344.

    Article  Google Scholar 

  40. Rand JH, Wu XX, Andree HA, et al.: Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism. N Engl J Med 1997, 337:154–160. [Published erratum in: N Engl J Med 1997, 337:1327.]

    Article  PubMed  CAS  Google Scholar 

  41. Van Horn JT, Craven C, Ward K, et al.: Histologic features of placentas and abortion specimens from women with anti-phospholipid and antiphospholipid-like syndromes. Placenta 2004, 25:642–648.

    Article  PubMed  CAS  Google Scholar 

  42. Di Simone N, Meroni PL, de Papa N, et al.: Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000, 43:140–150.

    Article  PubMed  Google Scholar 

  43. Sebire NJ, Fox H, Backos M, et al.: Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002, 17:1067–1071.

    Article  PubMed  CAS  Google Scholar 

  44. Salafia CM, Pezzullo JC, Ghidini A, et al.: Clinical correlations of patterns of placental pathology in preterm preeclampsia. Placenta 1998, 19:67–72.

    Article  PubMed  CAS  Google Scholar 

  45. Ishihara N, Natsuo H, Murakoshi H, et al.: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002, 186:158–166.

    Article  PubMed  Google Scholar 

  46. Yacobi S, Ornoy A, Blumenfeld Z, Miller RK: Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002, 66:300–308.

    Article  PubMed  CAS  Google Scholar 

  47. Albrecht C, Soumian S, Tetlow N, et al.: Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls. Placenta 2006, Epub ahead of print.

  48. Holers VM, Giradi G, Mo L, et al.: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211–220.

    Article  PubMed  CAS  Google Scholar 

  49. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002, 346:752–763.

    Article  PubMed  CAS  Google Scholar 

  50. Lockshin MD, Sammaritano LR, Schwartzman S: Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000, 43:440–443.

    Article  PubMed  CAS  Google Scholar 

  51. Silver RM, Branch DW: Autoimmune disease in pregnancy: Systemic lupus erythematosus and anti-phospholipid syndrome. Clin Perinatol 1997, 24:291–320.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, 30 North 1900 East, Room 2B200 SOM, Salt Lake City, UT, 84132, USA

    Robert M. Silver MD

Authors
  1. Erin A. S. Clark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert M. Silver MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Ware Branch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert M. Silver MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clark, E.A.S., Silver, R.M. & Ware Branch, D. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep 9, 219–225 (2007). https://doi.org/10.1007/s11926-007-0035-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0035-9

Keywords

Search

Navigation